Advertisement

Journal of Endocrinological Investigation

, Volume 35, Issue 1, pp 8–13 | Cite as

Total parathyroidectomy without autotransplantation in the surgical treatment of secondary hyperparathyroidism of chronic kidney disease

  • Giovanni ConzoEmail author
  • A. F. Perna
  • A. A. Sinisi
  • A. Palazzo
  • F. Stanzione
  • C. Delia Pietra
  • A. Livrea
Original Article
  • 94 Downloads

Abstract

Background: Subtotal parathyroidectomy (SP) and total parathyroidectomy (TP) with autotransplantation (TPai) are the most commonly adopted operations for the treatment of secondary hyperparathyroidism (2HPT). TP without autotransplantation had previously been confined to patients with advanced dialytic vintage, not eligible for kidney transplantation. Over the years, the procedure has gained more widespread use, but there is no precise knowledge on the immediate and long-term effects. Methods: The authors analyzed the immediate and long-term results of TP without autotransplantation, that is after the systematic removal of at least four glands in 20 patients operated for 2HPT, which were compared with results from TPai in an equal number of cases. Results: An improvement of the typical clinical symptoms was found in every patient undergoing surgery, and a significant reduction in intact PTH (iPTH) serum levels was achieved. Immediate normalization of iPTH level was observed in 11/20 TP cases, hypoparathyroidism in 4/20 and persistent HPT in 5/20 cases. One year of follow-up showed a slight increase in hypoparathyroidism, with 1/20 (5%) recurrence of the disease. One-year TPai results showed a similar percentage of euparathyroidism, as well as a higher long-term recurrence rate (4/20, 20%), although values do not reach statistical significance. Conclusions: TP may still be considered the operation of choice in patients with aggressive forms of 2HPT or of advanced dialytic vintage, with no access to renal transplantation, because of its low recurrence rate (5%). Post-operative aparathyroidism is rare, while hypoparathyroidism and hypocalcemia can be well controled by medical treatment.

Key-words

Autotransplantation chronic kidney disease parathyroidectomy secondary hyperparathyroidism 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Schlosser K, Veit JA, Witte S, et al. Comparison of total parathyroidectomy without autotransplantation and without thymectomy versus total parathyroidectomy with autotransplantation and with thymectomy for secondary hyperparathyroidectomy: TOPAR PlLOT-Trial. Trials 2007, 8: 22.PubMedCentralPubMedCrossRefGoogle Scholar
  2. 2.
    Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl 2009, (113): S1–130.Google Scholar
  3. 3.
    Esposito MG, Cesare CM, De Santo RM, et al. Parathyroidectomy improves the quality of sleep in maintenance hemodialysis patients with severe hyperparathyroidism. J Nephrol 2008, 21(Suppl 13): S92–6.PubMedGoogle Scholar
  4. 4.
    National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003, 42 (4 Suppl 3): S127–9.Google Scholar
  5. 5.
    Cunningham J, Danese M, Olson K, Klassen P, Chertow GM. Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism. Kidney Int 2005, 68: 1793–800.PubMedCrossRefGoogle Scholar
  6. 6.
    Fassbinder W, Brunner FP, Brynger H, et al. Combined report on regular dialysis and transplantation in Europe, XX, 1989. Nephrol Dial Transplant 1991, 6(Suppl 1): 5–35.Google Scholar
  7. 7.
    Tominaga Y. Surgical treatment of secondary hyperparathyroidism due to chronic kidney disease. Ups J Med Sci 2006, 111: 277–92.PubMedCrossRefGoogle Scholar
  8. 8.
    Kitagawa W, Shimizu K, Akasu H. Endocrine surgery: the tenth report diagnosis, surgical indications and operative strategy of renal hyperparathyroidism. J Nihon Med Sch 2003, 70: 278–82.CrossRefGoogle Scholar
  9. 9.
    Decker PA, Cohen EP, Doffek BS KM, et al. Subtotal parathyroidectomy in renal failure: still needed after all these years. World J Surg 2001, 25: 708–12.PubMedCrossRefGoogle Scholar
  10. 10.
    Malberti F, Marcelli D, Conte F, Limido A, Spotti D, Locatelli F. Parathyroidectomy in patients on renal replacement therapy: an epidemiologic study. J Am Soc Nephral 2001, 12: 1242–8.Google Scholar
  11. 11.
    Young EW, Albert JM, Satayathum S, et al. Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study. Kidney Int 2005, 67: 1179–87.PubMedCrossRefGoogle Scholar
  12. 12.
    Rodriguez M, Caravaca F, Fernandez E, et al. Parathyroid function as a determinant of the response to calcitriol treatment in the hemodialysis patient. Kidney Int 1999, 56: 306–17.PubMedCrossRefGoogle Scholar
  13. 13.
    Narayan R, Parkins RM, Berbano EP, et al. Parathyroidectomy versus cinacalcet hydrochloride-based medical terapy in the management of hyperparathyroidism in ESRD: a cost utility analysis. Am J Kidney Dis 2007, 49: 801–13.PubMedCrossRefGoogle Scholar
  14. 14.
    Ganesh SK, Stack AG, Levin NW, Hulbert-Shearon T, Port FK. Association of elevated serum PO(4), Ca × PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol 2001, 12: 2131–38.PubMedGoogle Scholar
  15. 15.
    Gasparri G, Camandona M, Mengozzi G, et al. Qu’est-ce que l’introduction du dosage peroperatoire de la PTH a changé dans les strategies chirurgicales des hyperparathyrodismes?. e-memoires de l’Académie Nationale de Chirurgie 2004, 3: 26–9.Google Scholar
  16. 16.
    Elizondo ME, Diaz Aguirregoitia FJ, Amondarain JA, Vidaur F. Intraoperative monitoring of intact PTH in surgery for renal hyperparathyroidisms as an indicator of complete parathyroid removal. World J Surg 2005; 29: 1504–9.CrossRefGoogle Scholar
  17. 17.
    Dotzenrath C, Cupisti K, Goretzki PE, et al. Operative treatment of renal autonomous hyperparathyroidism: cause of persistent or recurrent disease in 304 patients. Langenbecks Arch Surg 2003, 387: 348–54.PubMedGoogle Scholar
  18. 18.
    Richards ML, Wormuth J, Bingener J, Sirinek K. Parathyroidectomy in secondary hyperparathyroidism: is there an optimal operative management? Surgery 2006, 139: 174–80.PubMedCrossRefGoogle Scholar
  19. 19.
    Lorenz K, Ukkat J, Sekulla C, Gimm O, Brauckhoff M, Dralle H. Total parathyroidectomy without autotransplantation for renal hyperparathyroidism:experience with a qPTH-controlled protocol. World Journal Surgery 2006, 30: 743–51.CrossRefGoogle Scholar
  20. 20.
    Rayes N, Seehofer D, Schindler R, et al. Long term results of subtotal vs total parathyroidectomy without autotransplantation in kidney transplant recipients. Arch Surg 2008, 143: 756–60.PubMedCrossRefGoogle Scholar
  21. 21.
    Jofrè R, Lopez Gomez JM, Menàrguez J, et al. Parathyroidectomy: Whom and when? Kidney Int 2003, 63(Suppl 85) S97–100.CrossRefGoogle Scholar
  22. 22.
    Tominaga Y, Matsuoka S, Sato T. Surgical indications and procedures of parathyroidectomy in patients with chronic kidney disease. Ther Apher Dial 2005, 9: 44–7.PubMedCrossRefGoogle Scholar

Copyright information

© Italian Society of Endocrinology (SIE) 2012

Authors and Affiliations

  • Giovanni Conzo
    • 1
    Email author
  • A. F. Perna
    • 2
  • A. A. Sinisi
    • 3
  • A. Palazzo
    • 1
  • F. Stanzione
    • 1
  • C. Delia Pietra
    • 1
  • A. Livrea
    • 1
  1. 1.IV Division of General Surgery and Endocrine Surgery, Department of Clinical and Experimental Internal Medicine “F. Magrassi - A. Lanzara”Second University of MedicineNaplesItaly
  2. 2.I Division of NephrologySecond University of NaplesNaplesItaly
  3. 3.Division of EndocrinologySecond University of NaplesNaplesItaly

Personalised recommendations